490 filings
Page 4 of 25
6-K
mu7q 75xjy5d1
24 Nov 21
Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance
2:45pm
6-K
ub9r91
24 Nov 21
The National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer System
10:09am
6-K
fbnuwrj
9 Nov 21
Condensed Interim Consolidated Financial Statements
4:09pm
6-K
v30cp9bi5f80o
9 Nov 21
Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update
4:08pm
6-K
p5tcew87thdnk hvn0
1 Nov 21
Current report (foreign)
9:35am
6-K
sgq8qn 949ex7znv
21 Oct 21
Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery
9:07am
6-K
o7x 8mgx6dgcd
28 Sep 21
Current report (foreign)
9:05am
6-K
swoy827ux
23 Sep 21
Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
9:11am
6-K
e717 g1g3lm12mc
16 Sep 21
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
9:53am
6-K
kj3r8ftd6 otqgp
30 Aug 21
Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference
4:11pm
6-K
bkz8osn3x8ud2p6fbkw
17 Aug 21
Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA
12:08pm
6-K
enmgmb
16 Aug 21
Condensed Interim Consolidated Financial Statements
12:00am
6-K
ehyy4o9tg2z13w40y
13 Aug 21
Neovasc Announces Second Quarter 2021 Financial Results
8:36pm
6-K
9n8lyph
27 Jul 21
Current report (foreign)
9:05am
6-K
04f1 2nntg
13 Jul 21
Neovasc Announces New Appointments in Regulatory and Clinical Leadership
9:05am
6-K
s3x4rupt 5dy5wzvzg
21 Jun 21
Current report (foreign)
6:03am
6-K
5xvq870km l2trp4rl
10 Jun 21
Neovasc Provides Corporate Update
4:34pm
6-K
gf71qckr2bchve
7 Jun 21
Neovasc Reducer System Receives First National Reimbursement in Europe
9:14am
6-K
wl0t mhczos6m3
3 Jun 21
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
9:58pm
6-K
xovzj bs1ngix9ys2a
26 May 21
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
12:00am